ComInnex announces its acquisition by @XChemInc, expands expertise and scale in synthetic chem & DEL tech; driving innovative drug discovery solutions. Learn more: https://t.co/kYyE19GV4x
🔥Free🔥 Chemistry Europe Virtual Symposia connect the leading minds in the chemical sciences and bring cutting-edge research directly to you!
Save the date: Tue, Oct 19, 2021
➡https://t.co/tMH6z192Fm
💻 Join the EFMC and ChemBioChem on October 19, for their first joint symposium. Enjoy three exciting presentations with interactive question-and-answer sessions.
The event is free and open to all.
🔗 https://t.co/83o1qJ1zq3
Pioneering bespoke chemistry solutions.💡
When you need an experienced #customchemistry partner, consult with @cominnex for in-depth expertise in various aspects of innovative technology - for instance; #PROTAC technology or #DEL technology: https://t.co/4a8WGssQe1
#flowchemistry
🔥ComInnex is offering novel #compound sets, in stock and readily available for purchase
We provide #DEL Building Blocks; novel #screening sets; semi-rigid #linkers and E3 #ligase ligands for IAP and Cereblon.
Save time and reduce your screening efforts.
➡https://t.co/VxCc75WWhZ
📢Are you looking for a #career in the pharmaceutical industry?
Would you like to work in a multinational environment, with opportunities to grow with worldwide experience and expand your knowledge?
➡ Check our vacancies and apply today: https://t.co/1jEMHvlMNn
#researcherjobs
📌Novel Screening Compound Sets in Stock and Readily Available
We offer bespoke #screening sets from our Technology Enabled Compound Libraries.🧪
Save time, reduce screening efforts.
Check out our completely customised, lead-like libraries and #compounds: https://t.co/KyGoY2D5de
👉Free webinar by ThalesNano: ”Flow Chemistry Basics II.”
Save the date: September 28, Tuesday 5 pm CEST and September 30, Thursday 10 am CEST
📢Register now: https://t.co/giI0W1DokO
You still have the opportunity to register for our next free webinar ” Flow Chemistry Basics II.” which covers some hot topics.
Register here: https://t.co/FQ2m4S2Ixz
#webinar#flowchemistry#ThalesNano#AnywhereChem
📢 Validated DNA-Encoded Library Building Blocks from @cominnex
We offer DEL Building Blocks, validated for coupling efficiency under standard amide coupling conditions, with a primary amine functionalized DNA headpiece (HP-AOP).
➡ Learn more:https://t.co/PCPFekJ8Ke
#dna#dels
📢#PROTAC linkers and E3 ligase ligands in stock and readily available!
ComInnex offers immediately available novel Protein Degradation Toolkit linkers and sets of E3 ligase ligands.
Learn more here: https://t.co/RXMwqNLHNi
#drugdiscovery#tpd#molecularglue#smallmolecules
📢We are proud to announce that the PhotoCube™ Reactor, developed together with @thales_nano, has been selected as a finalist for the 2021 R&D Top100 Awards:https://t.co/fPDEwSK9xR
👉Learn more about our photochemistry opportunities: https://t.co/E6Vfrzv6ON
#photochemistry
📢We are proud to announce that the PhotoCube™ #Reactor, developed together with @thales_nano, has been selected as a #finalist for the 2021 R&D Top100 Awards: https://t.co/fPDEwT1KWr
👉Learn more about our #photochemistry opportunities: https://t.co/E6VfrzdvXf
#photocube
After holiday get used again to the working weekdays with ThalesNano and a stimulating webinar:
”How HydRegen’s biocatalytic hydrogenation technology lets you harness selective biocatalysis in the H-Cube”
Register here:https://t.co/bvr8LAxiv5
#webinar#ThalesNano#AnywhereChem
📢New #photochemistry application note!
Two-Step Telescoped Photocatalytic Minisci Reaction in Continuous Flow with the Phoenix Flow Reactor™ and the Photocube™
The study was undertaken in the laboratories of @cominnex and @thales_nano
👉Learn more: https://t.co/EEfjMp8SJ1
📢Unblock your Flow Chemistry service bottlenecks! Consult with #ComInnex on our in-depth expertise in various aspects of this innovative technology.
Check out our services and reach out to us to learn what we can do for you:
https://t.co/b4xf4HLV0X
#flowchemistry#synthesize
"Finding drugs that block the RNA-modifying protein known as METTL1 could provide people with aggressive brain, blood, skin and kidney cancers new treatment options in the future."☝️
The RNA-modifying protein METTL1 could be targeted to treat some types of aggressive cancers, including brain, blood and kidney.
#oncology#therapeutics#targets
Learn more here: https://t.co/1YENjYfn2F
ComInnex's collection of 200 #DEL#buildingblocks have been validated with respect to coupling efficiency with a primary amine functionalised #DNA headpiece (HP-AOP) under our standard amide coupling conditions. Learn more about our DEL synthesis services: https://t.co/T3QF2wrJ8l